Harrow Health 8625 Stock Performance
| HROWL Stock | USD 25.39 0.04 0.16% |
Harrow Health has a performance score of 9 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.0133, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Harrow Health are expected to decrease at a much lower rate. During the bear market, Harrow Health is likely to outperform the market. Harrow Health 8625 right now retains a risk of 0.28%. Please check out Harrow Health value at risk, as well as the relationship between the skewness and day median price , to decide if Harrow Health will be following its current trending patterns.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (0.04) | Five Day Return 0.52 | Year To Date Return 5.79 | Ten Year Return 2.01 | All Time Return 2.01 |
Dividend Date 2024-07-31 |
1 | Acquisition by Baum Mark L of 88000 shares of Harrow Health subject to Rule 16b-3 | 10/17/2024 |
2 | Acquisition by Opaleye Management Inc. of 1500 shares of Harrow Health at 8.6447 subject to Rule 16b-3 | 10/23/2024 |
3 | Acquisition by Lindstrom Richard L Md of 9644 shares of Harrow Health subject to Rule 16b-3 | 10/29/2024 |
| Harrow Health dividend paid on 31st of October 2024 | 10/31/2024 |
4 | Disposition of 14160 shares by Lindstrom Richard L Md of Harrow Health at 9.09 subject to Rule 16b-3 | 11/26/2024 |
| Begin Period Cash Flow | 96.3 M | |
| Free Cash Flow | -148.7 M |
Harrow |
Harrow Health Relative Risk vs. Return Landscape
If you would invest 2,487 in Harrow Health 8625 on September 1, 2024 and sell it today you would earn a total of 52.00 from holding Harrow Health 8625 or generate 2.09% return on investment over 90 days. Harrow Health 8625 is currently producing 0.0332% returns and takes up 0.2768% volatility of returns over 90 trading days. Put another way, 2% of traded stocks are less volatile than Harrow, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Harrow Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Harrow Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Harrow Health 8625, and traders can use it to determine the average amount a Harrow Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.12
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HROWL |
Estimated Market Risk
| 0.28 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Harrow Health is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harrow Health by adding it to a well-diversified portfolio.
Harrow Health Fundamentals Growth
Harrow Stock prices reflect investors' perceptions of the future prospects and financial health of Harrow Health, and Harrow Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Harrow Stock performance.
| Return On Equity | 0.45 | ||||
| Revenue | 130.19 M | ||||
| EBITDA | 9.72 M | ||||
| Net Income | (24.41 M) | ||||
| Total Debt | 190.5 M | ||||
| Cash Flow From Operations | 3.84 M | ||||
| Market Capitalization | 247.48 M | ||||
| Total Asset | 312.16 M | ||||
| Retained Earnings | (133.9 M) | ||||
About Harrow Health Performance
By examining Harrow Health's fundamental ratios, stakeholders can obtain critical insights into Harrow Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Harrow Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 100.06 | 92.81 | |
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | (0.34) | (0.36) |
Things to note about Harrow Health 8625 performance evaluation
Checking the ongoing alerts about Harrow Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Harrow Health 8625 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 130.19 M. Net Loss for the year was (24.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Harrow Health 8625 has a frail financial position based on the latest SEC disclosures | |
| On 31st of October 2024 Harrow Health paid $ 0.5391 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Disposition of 14160 shares by Lindstrom Richard L Md of Harrow Health at 9.09 subject to Rule 16b-3 |
- Analyzing Harrow Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Harrow Health's stock is overvalued or undervalued compared to its peers.
- Examining Harrow Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Harrow Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Harrow Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Harrow Health's stock. These opinions can provide insight into Harrow Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.